
|Articles|November 1, 2000
Supplements and Featured Publications
- Clinical and Economic Impact of Low-Molecular Weight Heparins in Managed Care
- Volume 6
- Issue 20 Suppl
Selected Abstracts
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
Introductionabout 25 years ago
Overview of Enoxaparin in the Treatment of DVTabout 25 years ago
DVT and Pulmonary Embolism in the Perioperative Patientabout 25 years ago
CME/CPE Article: Economics of Low-Molecular Weight Heparinsabout 25 years ago
CME/CPE QuizNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Communication of Launch Prices by Drug Companies, 2022-2024
2
FDA to Accept De-Identified Real-World Evidence for Select Medical Device Applications
3
Bispecifics in New Combos, New Uses, and Earlier Lines of Treatment in Myeloma
4
FDA Approves Once-Monthly PCSK9 Injection for LDL-C Reduction
5










































